CCM
ABBV icon

Cinctive Capital Management’s AbbVie ABBV Stock Holding History

Cinctive Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,000
Closed -$4.86M – 501
2022
Q1 		$4.86M Buy
+30,000
New +$4.36M 0.18% 184
2021
Q4 		– Sell
-250,000
Closed -$27M – 525
2021
Q3 		$27M Buy
+250,000
New +$28.6M 1.32% 3

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cinctive Capital Management's ABBV Position: Q4 2025 in Review

Cinctive Capital Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 39,816 shares — an estimated $9.22M sold.

Cinctive Capital Management first reported a position in ABBV in Q4 2019 and held it in 14 quarters. The position peaked at $16.2M in Q2 2021. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Cinctive Capital Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 39,816 AbbVie shares in Q4 2025, an estimated $9.22M.
  • Cinctive Capital Management first reported a position in AbbVie in Q4 2019 and held it in 14 quarters.
  • Cinctive Capital Management's AbbVie position peaked at $16.2M in Q2 2021.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.